Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 28 01:29PM ET
Dollar change
Percentage change
IndexRUT P/E11.62 EPS (ttm)2.47 Insider Own43.38% Shs Outstand59.62M Perf Week3.24%
Market Cap1.68B Forward P/E8.61 EPS next Y3.33 Insider Trans0.00% Shs Float33.16M Perf Month49.32%
Income150.75M PEG0.40 EPS next Q0.59 Inst Own63.01% Short Float / Ratio17.87% / 7.29 Perf Quarter-18.02%
Sales541.92M P/S3.10 EPS this Y-19.53% Inst Trans4.41% Short Interest5.93M Perf Half Y-18.27%
Book/sh8.22 P/B3.49 EPS next Y39.28% ROA21.21% Target Price40.78 Perf Year-50.65%
Cash/sh6.33 P/C4.53 EPS next 5Y28.80% ROE36.54% 52W Range18.61 - 62.08 Perf YTD-47.97%
Dividend- P/FCF9.92 EPS past 5Y- ROI22.69% 52W High-53.82% Beta0.69
Dividend %- Quick Ratio4.07 Sales past 5Y674.79% Gross Margin76.23% 52W Low54.05% ATR1.27
Employees200 Current Ratio4.12 Sales Q/Q36.74% Oper. Margin36.80% RSI (14)62.35 Volatility2.86% 4.39%
OptionableYes Debt/Eq0.41 EPS Q/Q-55.89% Profit Margin27.82% Rel Volume0.32 Prev Close28.79
ShortableYes LT Debt/Eq0.38 EarningsOct 31 BMO Payout0.00% Avg Volume812.30K Price28.67
Recom1.78 SMA2012.98% SMA504.24% SMA200-16.23% Volume165,098 Change-0.42%
Date Action Analyst Rating Change Price Target Change
Sep-25-23Downgrade Goldman Neutral → Sell $40 → $31
Sep-07-23Initiated Berenberg Buy $59
Apr-20-23Initiated BofA Securities Neutral $35
Oct-14-22Upgrade Jefferies Hold → Buy $57 → $61
Oct-14-22Upgrade Janney Neutral → Buy $57 → $61
Aug-03-22Downgrade Jefferies Buy → Hold $57
Jul-13-22Downgrade Goldman Buy → Neutral $55
Jul-07-22Initiated Mizuho Buy $64
Apr-14-22Initiated Cantor Fitzgerald Overweight $63
Dec-01-21Initiated Oppenheimer Outperform $55
Nov-16-23 08:05AM
Nov-15-23 08:05AM
Nov-13-23 09:55AM
Nov-08-23 09:40AM
09:50AM Loading…
Nov-06-23 09:50AM
Nov-03-23 11:40AM
Oct-31-23 06:00PM
Oct-26-23 08:05AM
Oct-25-23 10:02AM
Oct-24-23 10:00AM
Oct-20-23 12:08PM
08:05AM Loading…
Oct-17-23 08:05AM
Oct-13-23 12:52PM
Oct-11-23 08:00AM
Oct-05-23 08:05AM
Oct-04-23 09:25AM
Sep-27-23 08:00AM
Sep-25-23 10:41AM
Sep-20-23 08:05AM
Sep-15-23 09:00AM
Sep-13-23 08:05AM
Sep-09-23 03:59PM
Sep-07-23 12:12PM
08:05AM Loading…
Aug-28-23 08:00AM
Aug-22-23 08:14AM
Aug-14-23 11:06AM
Aug-03-23 05:56AM
Aug-01-23 02:30PM
Jul-31-23 11:58PM
Jul-27-23 08:05AM
Jul-25-23 08:05AM
Jul-20-23 08:05AM
Jul-18-23 08:05AM
Jun-29-23 07:00AM
Jun-22-23 09:30AM
Jun-21-23 08:00PM
Jun-12-23 08:30AM
Jun-06-23 08:05AM
May-30-23 08:05AM
May-25-23 08:05AM
May-10-23 08:05AM
May-03-23 06:19AM
May-02-23 02:30PM
May-01-23 08:54PM
Apr-26-23 08:00PM
Apr-24-23 08:05AM
Apr-20-23 08:05AM
Apr-19-23 02:42PM
Apr-16-23 02:01PM
Apr-12-23 12:35PM
Apr-09-23 01:19PM
Apr-03-23 12:36PM
Mar-30-23 03:47AM
Mar-29-23 08:05AM
Mar-28-23 02:17PM
Mar-21-23 04:13PM
Mar-06-23 08:05AM
Feb-28-23 08:05AM
Feb-23-23 10:50AM
Feb-21-23 06:00PM
Feb-17-23 08:05AM
Feb-07-23 01:51PM
Jan-31-23 10:06AM
Jan-30-23 08:28AM
Jan-25-23 10:37AM
Jan-18-23 05:00AM
Jan-11-23 07:56AM
Jan-09-23 10:29AM
Jan-06-23 04:39PM
Jan-02-23 09:33AM
Dec-30-22 12:52PM
Dec-26-22 09:38AM
Dec-22-22 08:05AM
Dec-09-22 01:11PM
Nov-25-22 02:10PM
Nov-23-22 08:54AM
Nov-18-22 02:08PM
Nov-09-22 08:05AM
Nov-02-22 07:57AM
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of neurological disorders. Its product, WAKIX, is a molecule with a novel mechanism of action designed to increase histamine signaling in the brain by binding to H3 receptors. The company was founded by Jeffrey S. Aronin on July 25, 2017 and is headquartered in Plymouth Meeting, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kapadia SandipCHIEF FINANCIAL OFFICERMar 29Option Exercise0.0030,000030,000Mar 31 04:26 PM
Nielsen JackDirectorDec 14Sale59.962,834169,9272,571,024Dec 16 07:15 PM
Wicki AndreasDirectorDec 14Sale60.001307,8002,147,943Dec 14 09:01 PM
Wicki AndreasDirectorDec 13Sale60.136,320380,0222,148,073Dec 14 09:01 PM
Wicki AndreasDirectorDec 12Sale60.3622,3911,351,5212,154,393Dec 14 09:01 PM
Nielsen JackDirectorDec 09Sale59.899,847589,7372,573,858Dec 09 08:34 PM
Nielsen JackDirectorDec 08Sale59.9036,8782,208,9922,583,705Dec 09 08:34 PM
Nielsen JackDirectorDec 07Sale60.3564,0263,863,9692,620,583Dec 09 08:34 PM
Wicki AndreasDirectorDec 05Sale61.2377,8534,766,9392,176,784Dec 07 09:00 PM
Serafin AndrewCHIEF STRATEGY OFFICERDec 02Option Exercise8.2238,000312,36038,000Dec 05 04:10 PM
Serafin AndrewCHIEF STRATEGY OFFICERDec 02Sale60.1338,0002,285,1000Dec 05 04:10 PM
Nielsen JackDirectorDec 01Sale60.0065,6523,939,1202,684,609Dec 01 07:52 PM
Nielsen JackDirectorNov 30Sale58.9342,6672,514,3662,750,261Dec 01 07:52 PM
Nielsen JackDirectorNov 29Sale57.8221,3331,233,4742,792,928Dec 01 07:52 PM